Third-generation Cephalosporins: a Review
Overview
Authors
Affiliations
Third-generation cephalosporins play a pivotal role in the management of infections because of their potent and broad-spectrum antimicrobial activity, proven clinical efficacy in a wide variety of infections, safety, and potential for cost savings. Selection of third-generation cephalosporins poses a dilemma, however, particularly for clinicians who view the six antibiotics within this class as interchangeable. Choice of drug should be based on antimicrobial spectrum and other factors such as lack of resistance development and cost considerations. This review focuses on the distinguishing features of the parenteral third-generation cephalosporins. Such differences suggest the need for retiring the convenient "generation" classification system for cephalosporins in favor of a system that encourages recognition of clinically important features of each agent in this diverse group of cephalosporin antibiotics.
Pharmacological properties of parenteral cephalosporins: rationale for ambulatory use.
Strehl E, Kees F Drugs. 2000; 59 Suppl 3:9-18; discussion 47-9.
PMID: 10845409 DOI: 10.2165/00003495-200059003-00002.
Antibiotics in neonatal infections: a review.
Fanos V, Dallagnola A Drugs. 1999; 58(3):405-27.
PMID: 10493270 DOI: 10.2165/00003495-199958030-00003.
Antibacterial-induced nephrotoxicity in the newborn.
Fanos V, Cataldi L Drug Saf. 1999; 20(3):245-67.
PMID: 10221854 DOI: 10.2165/00002018-199920030-00005.
Cephalosporin utilisation review and evaluation.
Misan G, Dollman C, Shaw D, Burgess N Pharmacoeconomics. 1995; 8(2):100-22.
PMID: 10155606 DOI: 10.2165/00019053-199508020-00003.
Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections.
Davis R, Bryson H Pharmacoeconomics. 1994; 6(3):249-69.
PMID: 10155268 DOI: 10.2165/00019053-199406030-00009.